Transactions
4
Insider / Cigna Group
ZARCONE DONNA F
Director at Cigna Group
- Company
- Cigna Group
- First filing on record
- December 12, 2025
- Latest trade on record
- April 22, 2026
- SEC filings
- EDGAR ↗
ZARCONE DONNA F, Director at Cigna Group, has disclosed 4 transactions in CI, CDW since December 12, 2025: 0 purchases (0 open-market buys) and 0 sales, worth about $8,865 at the reported prices. The latest was filed April 24, 2026, 2 days after the trade.
Open-market buys
0
Sales
0
Avg. disclosure lag
2.5d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months ZARCONE DONNA F reported 4 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 4 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 4 | 2,529 | $8,865 |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 0 |
| 2025 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| CI | Other A | April 22, 2026 | April 24, 2026 | 2d | 782 | — | — | Form 4 ↗ | ||
| CDW | Other A | March 10, 2026 | March 12, 2026 | 2d | 79 | — | — | Form 4 ↗ | ||
| CDW | Other A | March 5, 2026 | March 9, 2026 | 4d | 1,609 | — | — | Form 4 ↗ | ||
| CDW | Other A | December 10, 2025 | December 12, 2025 | 2d | 59 | $150 | $8,865 | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| April 24, 2026 | Form 4 | 0001739940-26-000034 | 1 | published | EDGAR ↗ |
| March 12, 2026 | Form 4 | 0001243083-26-000004 | 1 | published | EDGAR ↗ |
| March 9, 2026 | Form 4 | 0001243083-26-000002 | 1 | published | EDGAR ↗ |
| December 12, 2025 | Form 4 | 0001243083-25-000004 | 1 | published | EDGAR ↗ |
Other insiders at Cigna Group
- MEHROTRA SANJAY President and CEO 284 rows
- Cordani David Chairman & CEO 27 rows
- Kurian George Director 20 rows
- CONNELLY ELIZABETH H. See Remarks 14 rows
- Grier Kelly J Director 13 rows
- Evanko Brian C See Remarks 12 rows
- Jones Nicole S See Remarks 12 rows
- NELMS DAVID W Director 11 rows
- Foxx Anthony R Director 10 rows
- Hathi Neesha Director 10 rows
Everyone on file, with contracts and lobbying under the company's name: Cigna Group.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 4 | 4 | December 12, 2025 | April 24, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.